vs

Side-by-side financial comparison of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.

Velocity Financial, Inc. is the larger business by last-quarter revenue ($51.6M vs $44.6M, roughly 1.2× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). Velocity Financial, Inc. runs the higher net margin — 67.3% vs -90.4%, a 157.8% gap on every dollar of revenue. On growth, Velocity Financial, Inc. posted the faster year-over-year revenue change (32.8% vs 13.8%). Velocity Financial, Inc. produced more free cash flow last quarter ($17.9M vs $-19.9M). Over the past eight quarters, Velocity Financial, Inc.'s revenue compounded faster (32.3% CAGR vs 7.3%).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.

PACB vs VEL — Head-to-Head

Bigger by revenue
VEL
VEL
1.2× larger
VEL
$51.6M
$44.6M
PACB
Growing faster (revenue YoY)
VEL
VEL
+19.0% gap
VEL
32.8%
13.8%
PACB
Higher net margin
VEL
VEL
157.8% more per $
VEL
67.3%
-90.4%
PACB
More free cash flow
VEL
VEL
$37.8M more FCF
VEL
$17.9M
$-19.9M
PACB
Faster 2-yr revenue CAGR
VEL
VEL
Annualised
VEL
32.3%
7.3%
PACB

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PACB
PACB
VEL
VEL
Revenue
$44.6M
$51.6M
Net Profit
$-40.4M
$34.8M
Gross Margin
37.1%
Operating Margin
-92.3%
97.0%
Net Margin
-90.4%
67.3%
Revenue YoY
13.8%
32.8%
Net Profit YoY
-1802.7%
67.0%
EPS (diluted)
$-0.11
$0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACB
PACB
VEL
VEL
Q4 25
$44.6M
$51.6M
Q3 25
$38.4M
$49.1M
Q2 25
$39.8M
$47.6M
Q1 25
$37.2M
$37.5M
Q4 24
$39.2M
$38.9M
Q3 24
$40.0M
$35.1M
Q2 24
$36.0M
$32.4M
Q1 24
$38.8M
$29.5M
Net Profit
PACB
PACB
VEL
VEL
Q4 25
$-40.4M
$34.8M
Q3 25
$-38.0M
$25.4M
Q2 25
$-41.9M
$26.0M
Q1 25
$-426.1M
$18.9M
Q4 24
$2.4M
$20.8M
Q3 24
$-60.7M
$15.8M
Q2 24
$-173.3M
$14.8M
Q1 24
$-78.2M
$17.3M
Gross Margin
PACB
PACB
VEL
VEL
Q4 25
37.1%
Q3 25
41.4%
Q2 25
36.9%
Q1 25
-3.7%
Q4 24
25.6%
Q3 24
25.0%
Q2 24
16.5%
Q1 24
29.1%
Operating Margin
PACB
PACB
VEL
VEL
Q4 25
-92.3%
97.0%
Q3 25
-101.1%
72.1%
Q2 25
-112.8%
71.3%
Q1 25
-1154.5%
71.7%
Q4 24
-390.1%
82.5%
Q3 24
-160.3%
60.6%
Q2 24
-488.3%
61.3%
Q1 24
-209.6%
78.8%
Net Margin
PACB
PACB
VEL
VEL
Q4 25
-90.4%
67.3%
Q3 25
-98.9%
51.7%
Q2 25
-105.4%
54.6%
Q1 25
-1146.8%
50.4%
Q4 24
6.0%
53.5%
Q3 24
-151.9%
45.1%
Q2 24
-481.3%
45.6%
Q1 24
-201.4%
58.5%
EPS (diluted)
PACB
PACB
VEL
VEL
Q4 25
$-0.11
$0.90
Q3 25
$-0.13
$0.65
Q2 25
$-0.14
$0.69
Q1 25
$-1.44
$0.51
Q4 24
$-0.44
$0.56
Q3 24
$-0.22
$0.44
Q2 24
$-0.64
$0.42
Q1 24
$-0.29
$0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACB
PACB
VEL
VEL
Cash + ST InvestmentsLiquidity on hand
$279.5M
$92.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.3M
$672.5M
Total Assets
$784.1M
$7.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACB
PACB
VEL
VEL
Q4 25
$279.5M
$92.1M
Q3 25
$298.7M
$99.0M
Q2 25
$314.7M
$79.6M
Q1 25
$343.1M
$51.7M
Q4 24
$389.9M
$49.9M
Q3 24
$471.1M
$44.1M
Q2 24
$509.8M
$47.4M
Q1 24
$561.9M
$34.8M
Stockholders' Equity
PACB
PACB
VEL
VEL
Q4 25
$5.3M
$672.5M
Q3 25
$36.1M
$634.3M
Q2 25
$61.5M
$597.9M
Q1 25
$91.6M
$563.2M
Q4 24
$506.6M
$516.9M
Q3 24
$453.1M
$484.6M
Q2 24
$492.7M
$471.3M
Q1 24
$649.0M
$452.9M
Total Assets
PACB
PACB
VEL
VEL
Q4 25
$784.1M
$7.4B
Q3 25
$803.2M
$7.0B
Q2 25
$825.5M
$6.5B
Q1 25
$860.8M
$6.0B
Q4 24
$1.3B
$5.5B
Q3 24
$1.5B
$5.2B
Q2 24
$1.5B
$4.9B
Q1 24
$1.7B
$4.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACB
PACB
VEL
VEL
Operating Cash FlowLast quarter
$-19.1M
$18.2M
Free Cash FlowOCF − Capex
$-19.9M
$17.9M
FCF MarginFCF / Revenue
-44.6%
34.6%
Capex IntensityCapex / Revenue
1.9%
0.5%
Cash ConversionOCF / Net Profit
0.52×
TTM Free Cash FlowTrailing 4 quarters
$-114.1M
$40.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACB
PACB
VEL
VEL
Q4 25
$-19.1M
$18.2M
Q3 25
$-18.7M
$11.5M
Q2 25
$-29.4M
$7.7M
Q1 25
$-44.1M
$3.5M
Q4 24
$-30.6M
$37.8M
Q3 24
$-45.5M
$-17.6M
Q2 24
$-54.3M
$11.5M
Q1 24
$-75.7M
$10.6M
Free Cash Flow
PACB
PACB
VEL
VEL
Q4 25
$-19.9M
$17.9M
Q3 25
$-18.8M
$11.4M
Q2 25
$-29.9M
$7.6M
Q1 25
$-45.4M
$3.5M
Q4 24
$-32.3M
$37.5M
Q3 24
$-46.3M
$-17.6M
Q2 24
$-55.7M
$11.4M
Q1 24
$-79.6M
$10.5M
FCF Margin
PACB
PACB
VEL
VEL
Q4 25
-44.6%
34.6%
Q3 25
-48.9%
23.2%
Q2 25
-75.3%
15.9%
Q1 25
-122.3%
9.2%
Q4 24
-82.3%
96.4%
Q3 24
-115.7%
-50.3%
Q2 24
-154.8%
35.1%
Q1 24
-205.0%
35.8%
Capex Intensity
PACB
PACB
VEL
VEL
Q4 25
1.9%
0.5%
Q3 25
0.2%
0.1%
Q2 25
1.4%
0.2%
Q1 25
3.7%
0.2%
Q4 24
4.1%
0.7%
Q3 24
2.0%
0.2%
Q2 24
4.1%
0.3%
Q1 24
10.0%
0.1%
Cash Conversion
PACB
PACB
VEL
VEL
Q4 25
0.52×
Q3 25
0.45×
Q2 25
0.29×
Q1 25
0.19×
Q4 24
-12.93×
1.81×
Q3 24
-1.11×
Q2 24
0.78×
Q1 24
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

VEL
VEL

Related Party$19.3M37%
Nonrelated Party$16.9M33%
Other$15.4M30%

Related Comparisons